Jundishapur Journal of Natural Pharmaceutical Products, published by BRIEFLAND in the Netherlands, serves as a pivotal platform for researchers and professionals in the realm of pharmacology and toxicology. With its ISSN 1735-7780 and E-ISSN 2228-7876, the journal has established itself since its inception in 2011, showcasing a commitment to advancing knowledge in natural pharmaceutical products through innovative research. In 2023, it earned a commendable ranking in the Q3 category for Pharmacology, Toxicology, and Pharmaceutics, reflecting its contribution to the field as evidenced by its position in the Scopus rankings. The journal aims to publish high-quality research articles, reviews, and case studies that explore the potential benefits and toxicological aspects of natural products. Although it currently does not offer open access, its rigorous peer-review process ensures that only impactful studies are disseminated, ultimately facilitating a deeper understanding of natural pharmaceutical innovations. For those engaged in this exciting and evolving field, Jundishapur Journal of Natural Pharmaceutical Products is an essential resource that not only expands scholarly discourse but also promotes safe practices in natural product utilization.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

Journal of Traditional Chinese Medicine, with the ISSN 0255-2922 and E-ISSN 1577-7014, is a distinguished publication dedicated to exploring the rich heritage and contemporary applications of Chinese medicinal practices. Published by JOURNAL TRADITIONAL CHINESE MED in China, this journal contributes significantly to the field of Complementary and Alternative Medicine, holding a respectable Q2 ranking in this category according to the 2023 metrics, and a Q3 ranking in miscellaneous medicine. With its coverage spanning from 1996 to 2024, the journal aims to advance scholarly research and foster an understanding of traditional Chinese healing methodologies, blending ancient wisdom with modern healthcare paradigms. While currently not classified as Open Access, it provides critical insights and detailed analyses that are invaluable for researchers, healthcare professionals, and students interested in the intersection of tradition and innovation in medical practices.

The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.

The Journal of Ethnopharmacology, published by Elsevier Ireland Ltd, is a pivotal resource in the fields of Drug Discovery and Pharmacology, recognized as a Q1 journal in both categories as of 2023. With a rich history since its inception in 1979, this peer-reviewed journal provides a platform for rigorous research and innovative findings related to traditional medicinal practices and the therapeutic potential of natural products. The journal is ISSN 0378-8741 and E-ISSN 1872-7573, and it plays a vital role in advancing knowledge through its high-quality publications, which rank impressively at #35 out of 313 in Pharmacology and #19 out of 157 in Drug Discovery according to Scopus metrics. Although not open access, the journal aims to cater to a diverse audience of researchers, professionals, and students dedicated to exploring the intersection of ethnopharmacology and modern scientific inquiry. Its comprehensive scope encapsulates a multitude of studies spanning the globe, fostering a deeper understanding of how traditional practices can inform contemporary health solutions.

Chinese Medicine is a distinguished open-access journal published by BMC, focusing on the advancement of knowledge and practice in the domain of complementary and alternative medicine. With the ISSN 1749-8546, this journal has established itself as an important resource for researchers, professionals, and students interested in the integration of traditional Chinese medicine with modern scientific practices. Since its inception in 2006, it has garnered a notable reputation, achieving a Q1 ranking in Complementary and Alternative Medicine and Q2 in Pharmacology for 2023, reflecting its high impact and relevance within the academic community. The journal's commitment to disseminating quality research is evident in its Scopus rankings, placing it in the top decile for medicine and pharmacology disciplines. Open access since its launch, Chinese Medicine promotes widespread accessibility and encourages collaborative scholarly efforts in investigating the efficacy and applications of traditional practices in contemporary healthcare. By fostering a platform for rigorous discourse and innovative research, this journal serves as an essential conduit for advancing the understanding of Chinese medicine's role in global health.

PLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.

BMC Complementary Medicine and Therapies is a leading open-access journal published by BMC in the United Kingdom, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in the category of Complementary and Alternative Medicine as of 2023, and ranking #18 out of 105 in the Scopus database, placing it in the 83rd percentile among its peers. The journal’s mission is to disseminate high-quality research that contributes to a better understanding of the efficacy, safety, and practical application of complementary therapies. With its open-access model, BMC Complementary Medicine and Therapies ensures that valuable research findings are freely accessible to researchers, healthcare practitioners, and students alike, fostering collaboration and innovation across disciplines. The journal publishes original research, reviews, and clinical studies, providing a comprehensive platform for the exploration of diverse therapeutic modalities.

Phytotherapy Research, a distinguished journal published by Wiley, stands at the forefront of the pharmacological literature, delivering essential insights into the therapeutic potential of plant-based interventions. With its ISSN 0951-418X and E-ISSN 1099-1573, the journal has firmly established itself since its inception in 1987, now converging into its 2024 volume. Notably positioned in the Q1 category of Pharmacology and ranked #22 out of 313 journals in the field, it boasts a remarkable 93rd percentile rating according to Scopus. While the journal adheres to subscription-based access, it remains a crucial repository of high-quality research findings that support the understanding and advancement of herbal medicines and phytotherapeutics. This journal serves as an invaluable resource for researchers, healthcare professionals, and students alike, fostering a deeper exploration of the synergistic relationship between nature and medicine and promoting evidence-based practices in the field.

The Chinese Journal of Integrative Medicine, published by SPRINGER, serves as a pivotal platform for advancing the field of complementary and alternative medicine. Since its inception in 1995, this journal has been committed to disseminating high-quality research and innovative practices that integrate traditional Chinese medicine with modern medical science. With an impressive categorization in the 2023 metrics, ranking Q2 in Complementary and Alternative Medicine and Q3 in both Medicine (miscellaneous) and Pharmacology (medical), the journal highlights its recognition within the global academic landscape. Researchers and practitioners alike can benefit from its rigorous peer-reviewed articles, making significant contributions to the understanding and application of integrative health strategies. While it currently does not support open access, the journal remains a key resource for those dedicated to exploring the synergy between ancient practices and contemporary medical approaches, thus enhancing patient care and outcomes.